These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39141427)

  • 1. Multiple-dose pharmacokinetics of cenerimod and the effect of charcoal on its elimination.
    Mueller MS; Juif PE; Charfi H; Dingemanse J
    J Clin Pharmacol; 2024 Dec; 64(12):1566-1575. PubMed ID: 39141427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P₁ Receptor Modulator in Healthy Subjects.
    Juif PE; Baldoni D; Reyes M; Wilbraham D; Febbraro S; Vaclavkova A; Hoch M; Dingemanse J
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First use of cenerimod, a selective S1P
    Hermann V; Batalov A; Smakotina S; Juif PE; Cornelisse P
    Lupus Sci Med; 2019; 6(1):e000354. PubMed ID: 31798918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Pharmacodynamics of Cenerimod, A Selective S1P
    Juif PE; Dingemanse J; Winkle P; Ufer M
    Clin Transl Sci; 2021 Jan; 14(1):143-147. PubMed ID: 32860737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling pharmacokinetics and pharmacodynamics of the selective S1P
    Lott D; Juif PE; Dingemanse J; Krause A
    Br J Clin Pharmacol; 2020 Apr; 86(4):791-800. PubMed ID: 31756016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Effect of Cenerimod, a Selective S1P
    Juif PE; Mueller MS; Charfi H; Dingemanse J
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiodynamic Interactions between Two S1P
    Juif PE; Ufer M; Dingemanse J
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31266149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution, metabolism, and excretion of cenerimod, a selective S1P
    Boof ML; van Lier JJ; English S; Fischer H; Ufer M; Dingemanse J
    Xenobiotica; 2020 Aug; 50(8):947-956. PubMed ID: 32105166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, Tolerability, Pharmacokinetics and Quantitative Electroencephalography Assessment of ACD856, a Novel Positive Allosteric Modulator of Trk-Receptors Following Multiple Doses in Healthy Subjects.
    Önnestam K; Nilsson B; Rother M; Rein-Hedin E; Bylund J; Anderer P; Kemethofer M; Halldin MM; Sandin J; Segerdahl M
    J Prev Alzheimers Dis; 2023; 10(4):778-789. PubMed ID: 37874100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P
    Schlicher L; Kulig P; von Münchow A; Murphy MJ; Keller MP
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, safety, and tolerability of GLPG0259, a mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5) inhibitor, given as single and multiple doses to healthy male subjects.
    Namour F; Vanhoutte FP; Beetens J; Blockhuys S; De Weer M; Wigerinck P
    Drugs R D; 2012 Sep; 12(3):141-63. PubMed ID: 22950522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator.
    Skrumsager BK; Kiehr B; Pedersen PC; Gerrits M; Watson N; Bjarnason K
    Br J Clin Pharmacol; 2002 Mar; 53(3):284-95. PubMed ID: 11874392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of murine sclerodermatous models by the selective S1P
    Kano M; Kobayashi T; Date M; Tennichi M; Hamaguchi Y; Strasser DS; Takehara K; Matsushita T
    Sci Rep; 2019 Jan; 9(1):658. PubMed ID: 30679645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of Attainment of Steady-State Conditions for Compounds With a Long Half-Life.
    Krause A; Lott D; Dingemanse J
    J Clin Pharmacol; 2021 Jan; 61(1):82-89. PubMed ID: 32656870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects.
    Cheung D; Fong A; Ding HT; Cabanski CR; Wang J; Chen Y; Bush J; Harris JM; Pan L
    Pulm Pharmacol Ther; 2021 Aug; 69():102051. PubMed ID: 34166834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
    Taylor L; Gidal B; Blakey G; Tayo B; Morrison G
    CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-Ascending Dose Study in Healthy Subjects to Assess the Pharmacokinetics, Tolerability, and CYP3A4 Interaction Potential of the T-Type Calcium Channel Blocker ACT-709478, A Potential New Antiepileptic Drug.
    Richard M; Kaufmann P; Ort M; Kornberger R; Dingemanse J
    CNS Drugs; 2020 Mar; 34(3):311-323. PubMed ID: 31994022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cenerimod, a selective S1P
    Gerossier E; Nayar S; Froidevaux S; Smith CG; Runser C; Iannizzotto V; Vezzali E; Pierlot G; Mentzel U; Murphy MJ; Martinic MM; Barone F
    Arthritis Res Ther; 2021 Nov; 23(1):289. PubMed ID: 34839819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.
    Stass H; Kubitza D; Möller JG; Delesen H
    Br J Clin Pharmacol; 2005 May; 59(5):536-41. PubMed ID: 15842551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.